Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Regan Schuetze
Observed name:
Regan J. Schuetze
Institutions:
The University of Texas Medical Branch at Galveston,
The University of Texas Southwestern Medical Center
Observed institutions:
Baylor University,
The University of Texas Medical Branch at Galveston,
The University of Texas Southwestern Medical Center
ORCID:
0000-0002-2735-2300
Observed ORCID:
0000-0002-2735-2300
OpenAlex ID:
A5027096278
Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors
2021
·
li Liu
, Devin O’Kelly
, et al.
·
Molecules
·
29
PDF
Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment
2022
·
Li Liu
, Regan Schuetze
, et al.
·
Cancers
·
8
A brain‐derived tau oligomer polymorph is associated with cognitive resilience to Alzheimer's disease
2025
·
Michela Marcatti
, Batbayar Tumurbaatar
, et al.
·
Alzheimer s & Dementia
·
6
PDF
Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice
2025
·
Hashini I. Wanniarachchi
, Regan Schuetze
, et al.
·
Cancers
·
5
Benzosuberene and Tetracyclic Analogues as Colchicine Site Inhibitors of Tubulin Polymerization
2025
·
Jennifer M. VanNatta
, Graham J. Carlson
, et al.
·
ACS Medicinal Chemistry Letters
·
3
Abstract 2086 Preliminary pharmacokinetic study of OXi8007, an effective vascular disrupting agent, in an orthotopic RENCA tumor-bearing BALB/c mouse model
2024
·
Yuling Deng
, Caleb Tamminga
, et al.
·
Journal of Biological Chemistry
PDF
Abstract 6206: Discerning vasculature destruction caused by novel vascular disrupting agents examined by optical and multispectral optoacoustic imaging
2022
·
Hashini I. Wanniarachchi
, Regan Schuetze
, et al.
·
Cancer Research
Show more works
View as search
Works count:
7
Citation count:
51
H-index:
4
I10-index:
1
Year
Topic
Type